TY - JOUR
T1 - Karyotype in acute mybloblastic leukemia (AML)
T2 - Prognostic significance in bone marrow transplantation in first remission (CR1) a study from Ike scttt leukemia working-party of the European Cooperative Group foe Bknd and Marrow Transplanlaobi (EBMT) NC
AU - Labonin, Forin M.
AU - Frassoni, F.
AU - Prenitice, H. G.
AU - Caba, J. Y.
AU - Reiffers, J.
AU - Boogaerts, M.
AU - Bandini, G.
AU - Lowernberg, B.
AU - Attal, M.
AU - Ferrant, A.
PY - 1996
Y1 - 1996
N2 - The cylojoielic due of 999 AML pitocs who lud BMT in CR1 hive been ulysed. The karyotypes atiu45), K1S;17) (n-80), 1(831) (->). Ita 5 nd/oi 7 (..50). bu llq (.-33), pieudodkiloid (n.72), hypodiploid (1.24), hyperdipbid (nrf6), or diploU (n-bi llq. pnudodinloidy, hyperdiploidy or with normal kuyotype did not differ. This group of pUieMa hid bead survivil, rorutlil dunliog nd kukemil free survival (LFS) probability than the group of patients with abn 5 and/or 7 or hypodiptady (survival: 0.54 vs 0.23, p-0.00005; remisaioB duration: 0.62 vs 0.21, p-0-000001; LPS: 0.50 vs 0.17,p-0.000008). The outcomes of AUoBMT and ABMT patients with unfavorable cylogenetics were simuar. When conparkl AUoBMT and ABMT in patients with favorable cytogenelio, AUoBMT was of benefit for remisBR duration (p
AB - The cylojoielic due of 999 AML pitocs who lud BMT in CR1 hive been ulysed. The karyotypes atiu45), K1S;17) (n-80), 1(831) (->). Ita 5 nd/oi 7 (..50). bu llq (.-33), pieudodkiloid (n.72), hypodiploid (1.24), hyperdipbid (nrf6), or diploU (n-bi llq. pnudodinloidy, hyperdiploidy or with normal kuyotype did not differ. This group of pUieMa hid bead survivil, rorutlil dunliog nd kukemil free survival (LFS) probability than the group of patients with abn 5 and/or 7 or hypodiptady (survival: 0.54 vs 0.23, p-0.00005; remisaioB duration: 0.62 vs 0.21, p-0-000001; LPS: 0.50 vs 0.17,p-0.000008). The outcomes of AUoBMT and ABMT patients with unfavorable cylogenetics were simuar. When conparkl AUoBMT and ABMT in patients with favorable cytogenelio, AUoBMT was of benefit for remisBR duration (p
UR - http://www.scopus.com/inward/record.url?scp=33748592563&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33748592563&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:33748592563
VL - 24
SP - 1124
JO - Experimental Hematology
JF - Experimental Hematology
SN - 0301-472X
IS - 9
ER -